Skip to main content
BGLC logo

BGLC · BioNexus Gene Lab Corp

Track BGLC — free
$1.47 -0.02 (-1.34%) At close · Sep 1
Market Cap
$4.37M
Shares
2.93M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 3
Total Value: $28,048
Total Shares: 14,385

Institutional Ownership Trend

12 quarters

Holder Concentration

Across 3 13F filers · Δ vs Mar 31, 2026
Top Holder
99.3%
Sep 2023 → Jun 2026 · range 29.3% – 100.0%
−0.3 pts
Top 5
100.0%
Sep 2023 → Jun 2026 · range 99.7% – 100.0%
0.0 pts
Top 10
100.0%
Sep 2023 → Jun 2026 · range 100.0% – 100.0%
0.0 pts
HHI
9,861
Sep 2023 → Jun 2026 · range 2,267 – 10,000
Highly concentrated−59

Quarterly Activity

vs Mar 31, 2026
New
2
Increased
0
Decreased
1
Sold Out
1
Unchanged
0
Holder count: +1
Institutional value: +5554.8%
Shares held: +6100.4%

Top Buyers

vs Mar 31, 2026
No qualifying movers this quarter.

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 3 of 3
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1737523 CUSIP 090628306 13F (30d) 4 filings 4 filers Visit website Investor relations